News
The Joint Society for Neuro-Oncology (SNO) and the American Society of Clinical Oncology (ASCO) focus on the rapidly evolving area of central nervous system metastases ...
Presentation by trial principal investigator at the 2025 SNO/ASCO CNS Metastases Conference Plus will also host an ...
The administration of U.S. President Donald Trump continues to ramp up the pressure on American universities and scientific ...
There is no evidence the footage was deceptively manipulated, but ambiguities around how the video was processed may further ...
Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for ...
AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.
Yet greater awareness of sleep deprivation’s consequences hasn’t translated into a better-rested populace. Data from the CDC ...
This Iowa distiller created a whiskey to mark her grandfather’s WWII service. Now it’s a salve for veterans — and the ...
America’s largest trade partner is awaiting word on whether U.S. President Donald Trump will impose punishing tariffs on its ...
Some streets were still empty — even those with buildings intact — the homes empty and waiting for their people to return.
Starting at Rs 31,999, OnePlus Nord 5 brings serious flagship ambition to the mid-range segment. It may lose on the all-metal ...
SNMMI 2025: Development of PSMA Targeting Radioligand 161Tb-LNC1011 for Prostate Cancer Theranostics
SNMMI annual meeting featured a radiotheranostics session and a presentation by Dr. Xuejen Wen discussing the development of PSMA targeting radioligand 161 Tb-LNC1011 for prostate cancer theranostics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results